Patents by Inventor Wanda Dischert

Wanda Dischert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11814663
    Abstract: The present invention concerns a new mutant strain of Clostridium acetobutylicum comprising attenuated glycerol kinase activity. In addition, the present invention concerns a consortium of Clostridium comprising at least said mutant strain and at least one other species of Clostridium chosen among C. sporogenes and C. sphenoides. As this modified strain may be adapted for growth and for the production of 1,3-propanediol in an appropriate culture medium with high glycerol content, the invention also relates to a method for the production of 1,3-propanediolandbutyric acid, by culturing at least this mutant strain in an appropriate culture medium.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: November 14, 2023
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Céline Raynaud, Laurence Dumon-Seignovert, Nadège Dumoulin
  • Publication number: 20210254108
    Abstract: The present invention concerns a new mutant strain of Clostridium acetobutylicum comprising attenuated glycerol kinase activity. In addition, the present invention concerns a consortium of Clostridium comprising at least said mutant strain and at least one other species of Clostridium chosen among C. sporogenes and C. sphenoides. As this modified strain may be adapted for growth and for the production of 1,3-propanediol in an appropriate culture medium with high glycerol content, the invention also relates to a method for the production of 1,3-propanediol and butyric acid, by culturing at least this mutant strain in an appropriate culture medium.
    Type: Application
    Filed: August 9, 2019
    Publication date: August 19, 2021
    Applicant: METABOLIC EXPLORER
    Inventors: Wanda DISCHERT, Céline RAYNAUD, Laurence DUMON-SEIGNOVERT, Nadège DUMOULIN
  • Patent number: 10858675
    Abstract: The present invention relates to a recombinant microorganism capable of producing 2,4-dihydroxybutyrate, which is characterized by an increased cellular export, and preferably by a decreased cellular import, of said 2,4 DHB. The invention also relates to a method for the optimized production of 2,4-dihydroxybutyrate by culturing said microorganism in a fermentation medium and recovering 2,4-DHB from said medium.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: December 8, 2020
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Laurence Dumon-Seignovert, Perrine Vasseur, Gwénaëlle Bestel-Corre, Philippe Soucaille
  • Patent number: 10774320
    Abstract: The present invention relates to methods and recombinant microorganisms useful for the production of glycolic acid and/or glyoxylic acid. The methods of the invention involve either only one step of fermentation of the modified microorganisms of the invention or one step of fermentation of the modified microorganisms of the invention and one step of either biological or chemical conversion of the glycolic acid or of the glyoxylic acid, the microorganism of the invention over expressing a phosphoketolase gene.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: September 15, 2020
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Gwenaëlle Corre, Philippe Soucaille
  • Publication number: 20190367898
    Abstract: The present invention relates to methods and recombinant microorganisms useful for the production of glycolic acid and/or glyoxylic acid. The methods of the invention involve either only one step of fermentation of the modified microorganisms of the invention or one step of fermentation of the modified microorganisms of the invention and one step of either biological or chemical conversion of the glycolic acid or of the glyoxylic acid, the microorganism of the invention over expressing a phosphoketolase gene.
    Type: Application
    Filed: January 26, 2018
    Publication date: December 5, 2019
    Applicant: METABOLIC EXPLORER
    Inventors: Wanda DISCHERT, Gwenaëlle CORRE, Philippe SOUCAILLE
  • Patent number: 10385322
    Abstract: The present invention concerns a method for the production of derivatives of 4-hydroxy-2-ketobutyrate chosen among 1,3-propanediol or 2,4-dihydroxybutyrate by culturing a genetically modified microorganism for the production of the desired derivative of 4-hydroxy-2-ketobutyrate, the microorganism further comprising a gene coding for a mutant glutamate dehydrogenase converting by deamination L-homoserine into 4-hydroxy-2-ketobutyrate. The invention also concerns said genetically modified microorganism.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: August 20, 2019
    Assignee: METABOLIC EXPLORER
    Inventors: Zhen Chen, Feng Geng, An-Ping Zeng, Wanda Dischert, Philippe Soucaille
  • Patent number: 10329591
    Abstract: The present invention is related to a recombinant microorganism optimized for the fermentative production of methionine and/or its derivatives, wherein in said recombinant strain, the methionine efflux is enhanced by overexpressing the homologous logous genes of ygaZ and ygaH genes from Escherichia coli. It is also related to a method for optimizing the fermentative production of methionine or its derivatives comprising the steps of: a. culturing a recombinant microorganism wherein in said microorganism, the methionine efflux is enhanced by overexpressing the ygaZH homologous genes of ygaZ and ygaH genes from Escherichia coli, in an appropriate culture medium comprising a fermentable source of carbon and a source of sulphur, and b. recovering methionine and/or its derivatives from the culture medium.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: June 25, 2019
    Assignee: Evonik Degussa GmbH
    Inventors: Rainer Figge, Laurence Dumon-Seignovert, Perrine Vasseur, Wanda Dischert
  • Patent number: 10196658
    Abstract: The present application is related to a recombinant microorganism optimized for the fermentative production of methionine and/or its derivatives, wherein in said recombinant microorganism, the cobalamin-dependent methionine synthase activity and the methionine efflux are enhanced. The application is also related to a method for optimizing the fermentative production of methionine and/or its derivatives comprising the steps of: c. culturing a recombinant microorganism wherein in said microorganism, the cobalamin-dependent methionine synthase activity and the methionine efflux are enhanced, in an appropriate culture medium comprising a fermentable source of carbon and a source of sulphur, and d. recovering methionine and/or its derivatives from the culture medium.
    Type: Grant
    Filed: September 1, 2014
    Date of Patent: February 5, 2019
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Wanda Dischert, Perrine Vasseur, Rainer Figge
  • Publication number: 20180105845
    Abstract: The present invention relates to a recombinant microorganism capable of producing 2,4-dihydroxybutyrate, which is characterized by an increased cellular export, and preferably by a decreased cellular import, of said 2,4 DHB. The invention also relates to a method for the optimized productionof 2,4-dihydroxybutyrate by culturing said microorganism in a fermentation medium and recovering 2,4-DHB from said medium.
    Type: Application
    Filed: April 7, 2016
    Publication date: April 19, 2018
    Applicant: METABOLIC EXPLORER
    Inventors: Wanda DISCHERT, Laurence DUMON-SEIGNOVERT, Perrine VASSEUR, Gwénaëlle BESTEL-CORRE, Philippe SOUCAILLE
  • Publication number: 20170240868
    Abstract: The present invention concerns a method for the production of derivatives of 4-hydroxy-2-ketobutyrate chosen among 1,3-propanediol or 2,4-dihydroxybutyrate by culturing a genetically modified microorganism for the production of the desired derivative of 4-hydroxy-2-ketobutyrate, the microorganism further comprising a gene coding for a mutant glutamate dehydrogenase converting by deamination L-homoserine into 4-hydroxy-2-ketobutyrate. The invention also concerns said genetically modified microorganism.
    Type: Application
    Filed: October 2, 2015
    Publication date: August 24, 2017
    Applicant: METABOLIC EXPLORER
    Inventors: Zhen CHEN, Feng GENG, An-Ping ZENG, Wanda DISCHERT, Philippe SOUCAILLE
  • Publication number: 20170240938
    Abstract: The present invention is related to a recombinant microorganism optimised for the fermentative production of methionine and/or its derivatives, wherein in said recombinant strain, the methionine efflux is enhanced by overexpressing the homologous logous genes of ygaZ and ygaH genes from Escherichia coli. It is also related to a method for optimising the fermentative production of methionine or its derivatives comprising the steps of: a. culturing a recombinant microorganism wherein in said microorganism, the methionine efflux is enhanced by overexpressing the ygaZH homologous genes of ygaZ and ygaH genes from Escherichia coli, in an appropriate culture medium comprising a fermentable source of carbon and a source of sulphur, and b. recovering methionine and/or its derivatives from the culture medium.
    Type: Application
    Filed: August 31, 2015
    Publication date: August 24, 2017
    Applicant: METABOLIC EXPLORER
    Inventors: Rainer FIGGE, Laurence DUMON-SEIGNOVERT, Perrine VASSEUR, Wanda DISCHERT
  • Patent number: 9506092
    Abstract: The present invention is related to a recombinant microorganism for improved methionine production comprising modifications to produce methionine from glucose as main carbon source by fermentation, and modifications to improve glucose import, wherein the glucose import is improved by modifying the expression of at least one gene selected from ptsG, sgrT sgrS and dgsA. The invention is also related to a method for the fermentative production of methionine or methionine derivatives comprising the steps of: culturing the recombinant microorganism as described above in an appropriate culture medium comprising a fermentable source of carbon containing glucose and a source of sulphur, and recovering methionine or methionine derivatives from the culture medium.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: November 29, 2016
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Rainer Figge
  • Patent number: 9506093
    Abstract: The present invention is related to a recombinant microorganism optimized for the fermentative production of methionine, wherein the activity of the cobalamin-independent methionine synthase MetE is attenuated in said microorganism. The invention is also related to a method for producing methionine by fermentation.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: November 29, 2016
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Rainer Figge
  • Publication number: 20160177352
    Abstract: The present application is related to a recombinant microorganism optimised for the fermentative production of methionine and/or its derivatives, wherein in said recombinant microorganism, the cobalamin-dependent methionine synthase activity and the methionine efflux are enhanced. The application is also related to a method for optimizing the fermentative production of methionine and/or its derivatives comprising the steps of: c. culturing a recombinant microorganism wherein in said microorganism, the cobalamin-dependent methionine synthase activity and the methionine efflux are enhanced, in an appropriate culture medium comprising a fermentable source of carbon and a source of sulphur, and d. recovering methionine and/or its derivatives from the culture medium.
    Type: Application
    Filed: September 1, 2014
    Publication date: June 23, 2016
    Applicant: METABOLIC EXPLORER
    Inventors: Wanda DISCHERT, Perrine VASSEUR, Rainer FIGGE
  • Publication number: 20150247175
    Abstract: The present invention is related to a recombinant microorganism optimised for the fermentative production of methionine, wherein the activity of the cobalamin-independent methionine synthase MetE is attenuated in said microorganism. The invention is also related to a method for producing methionine by fermentation.
    Type: Application
    Filed: June 18, 2012
    Publication date: September 3, 2015
    Inventors: Wanda Dischert, Rainer Figge
  • Patent number: 9121043
    Abstract: The present invention relates to use of inducible promoters in the production of glycolic acid by fermentation. The present invention concerns a method for the production of glycolic acid in a fermentative process comprising the following steps: culturing a modified microorganism in an appropriate culture medium comprising a source of carbon, modulating in said microorganism the expression of a target gene with an external stimulus, and recovering glycolic acid from the culture medium, wherein in said modified microorganism, the expression of at least one gene involved in glycolic acid production is under the control of a heterologous inducible promoter whose activity is modulated with said external stimulus. The invention also concerned the modified microorganism used in the method of glycolic acid production.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: September 1, 2015
    Assignee: METABOLIC EXPLORER
    Inventors: Wanda Dischert, Rainer Figge, Philippe Soucaille
  • Patent number: 9034611
    Abstract: The present invention is related to a microorganism for the production of methionine, wherein said microorganism is modified to enhance the transhydrogenase activity of PntAB. In a preferred aspect of the invention, the activity of the transhydrogenase UdhA is attenuated in said microorganisms. The invention also related to a method for producing methionine by fermentation.
    Type: Grant
    Filed: October 24, 2011
    Date of Patent: May 19, 2015
    Assignee: METALBOLIC EXPLORER
    Inventors: Wanda Dischert, Perrine Vasseur, Cédric Boisart, Rainer Figge
  • Patent number: 9023624
    Abstract: The present invention is related to a method for the fermentative production of hydroxymethionine, comprising the steps of: culturing a recombinant microorganism modified to produce methionine in an appropriate culture medium comprising a source of carbon, a source of sulfur and a source of nitrogen, recovering hydroxymethionine from the culture medium. In a specific embodiment, the recombinant microorganism is cultivated under conditions of nitrogen limitation. The invention is also related to the biologically-produced hydroxymethionine and its uses.
    Type: Grant
    Filed: December 30, 2010
    Date of Patent: May 5, 2015
    Assignee: Metabolic Explorer
    Inventors: Rainer Figge, Wanda Dischert
  • Patent number: 8945888
    Abstract: The present invention relates to an improved method for the bioconversion of a fermentable carbon source to glycolic acid by a recombinant microorganism bearing new genetic modifications such as ?ldhA, ?mgsA, ?arcA, and ?lldP, ?glcA, ?yjcG and combination of them allowing a production with higher yield, titer and productivity.
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: February 3, 2015
    Assignee: Metabolic Explorer
    Inventors: Wanda Dischert, Philippe Soucaille
  • Publication number: 20140342419
    Abstract: The present invention is related to a recombinant microorganism engineered for the production of 2,3-butanediol (BDO), wherein said microorganism overexpresses at least one gene encoding a polypeptide involved in the conversion of pyruvate into 2,3-butanediol. The invention is also related to a method of production of 2,3-butanediol comprising the following steps: providing a recombinant microorganism as described above, cultivating the recombinant microorganism in a culture medium containing a source of carbon, and recovering the 2,3-butanediol.
    Type: Application
    Filed: November 21, 2012
    Publication date: November 20, 2014
    Inventors: Wanda Dischert, Guillaume Letellier, Rainer Figge, Véronique Douchin